u 37883a has been researched along with 8-(4-((2-aminoethyl)aminocarbonylmethyloxy)phenyl)-1,3-dipropylxanthine in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Choe, EU; Cruz, MP; Ferrara, JJ; Flint, LM; Hyman, AL; Lippton, HL; Pigott, JD; Sabates, BL | 1 |
1 other study(ies) available for u 37883a and 8-(4-((2-aminoethyl)aminocarbonylmethyloxy)phenyl)-1,3-dipropylxanthine
Article | Year |
---|---|
Adrenomedullin mediates coronary vasodilation through adenosine receptors and KATP channels.
Topics: Adamantane; Adenosine Triphosphate; Adrenomedullin; Animals; Calcitonin Gene-Related Peptide; Calcitonin Gene-Related Peptide Receptor Antagonists; Coronary Circulation; Coronary Vessels; Dogs; Morpholines; Peptide Fragments; Peptides; Potassium Channels; Receptors, Purinergic P1; Vascular Resistance; Vasodilation; Xanthines | 1997 |